我国各地药品风险管理实践比较研究  

Comparative Analysis on the Practice of Drug Risk Management in China

作　　者：徐徕[1,2] 余伯阳[1] 

机构地区：[1]中国药科大学国际医药商学院,南京市210009 [2]上海市食品药品安全研究中心,上海市200233

出　　处：《中国药房》2010年第41期3848-3852,共5页China Pharmacy

摘　　要：目的:为建立统一完善的药品风险管理体系提供合理建议。方法:以"药品"、"风险管理"为关键词,搜索2007年来中文期刊全文数据库和各大网站的相关文献(报道)132篇,运用案例分析法、实践经验总结法、比较分析法等多种研究方法,对我国各地药品风险管理实践做法进行深入分析,以期为我国药品风险管理模式的完善提供实践依据。结果与结论:我国药品风险管理体系应总结各地经验,从研发、生产、流通、使用4个环节进行改进,加强药品风险管理的全程控制以及应急机制的完善。OBJECTIVE：To supply references for the establishment of united system of drug risk management.METHODS：Using ＂drug＂ and ＂risk management＂ as Keywords ,132 literatures and reports were retrieved from CNKI and websites in 2007.Case analysis,experiences summary,comparative analysis were adopted to analyze the practice of drug risk management in China,so that it can provide practical references for the improvement of drug risk management.RESULTS CONCLUSIONS：The system of drug risk management in China should be improved in respect of research,produce,circulation and usage based on the experience of all parts of country.We still need to enhance the thorough control of drug risk management and improvement of emergency mechanism.

关 键 词：我国 各地 药品风险管理 实践 比较 

分 类 号：R95[医药卫生—药学]